TD Capital Management’s Aspen Aerogels ASPN Stock Holding History

TD Capital Management’s Portfolio ASPN Stock Details ASPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22	Closed	-$141	–	707
2025 Q1	$141	Buy	+22	New	+$212	﹤0.01%	684

Other funds holding ASPN

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

TD Capital Management's ASPN Position: Q2 2025 in Review

TD Capital Management sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 22 shares — an estimated $141 sold.

TD Capital Management first reported a position in ASPN in Q1 2025 and held it in 1 quarter. The position peaked at $141 in Q1 2025. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

TD Capital Management reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
TD Capital Management sold 22 Aspen Aerogels shares in Q2 2025, an estimated $141.
TD Capital Management first reported a position in Aspen Aerogels in Q1 2025 and held it in 1 quarter.
TD Capital Management's Aspen Aerogels position peaked at $141 in Q1 2025.
182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on TD Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.